These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 2999224)
1. Hepatic encephalopathy. Experimental studies in a rat model of fulminant hepatic failure. Zeneroli ML J Hepatol; 1985; 1(3):301-11. PubMed ID: 2999224 [TBL] [Abstract][Full Text] [Related]
2. Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Baraldi M; Zeneroli ML; Ventura E; Penne A; Pinelli G; Ricci P; Santi M Clin Sci (Lond); 1984 Aug; 67(2):167-75. PubMed ID: 6086210 [TBL] [Abstract][Full Text] [Related]
3. Visual evoked potentials in a rabbit model of hepatic encephalopathy. II. Comparison of hyperammonemic encephalopathy, postictal coma, and coma induced by synergistic neurotoxins. Pappas SC; Ferenci P; Schafer DF; Jones EA Gastroenterology; 1984 Mar; 86(3):546-51. PubMed ID: 6693016 [TBL] [Abstract][Full Text] [Related]
4. Supersensitivity of GABA-A receptors in hepatic encephalopathy. Baraldi M Neurochem Res; 1990 Feb; 15(2):153-60. PubMed ID: 2159120 [TBL] [Abstract][Full Text] [Related]
5. Gamma-aminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. Schafer DF; Fowler JM; Munson PJ; Thakur AK; Waggoner JG; Jones EA J Lab Clin Med; 1983 Dec; 102(6):870-80. PubMed ID: 6315836 [TBL] [Abstract][Full Text] [Related]
6. [Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure]. Jones EA; Ferenci P; Pappas SC; Schafer DF Leber Magen Darm; 1984 Nov; 14(6):282-7. PubMed ID: 6151107 [TBL] [Abstract][Full Text] [Related]
7. Reversal of the behavioral and electrophysiological abnormalities of an animal model of hepatic encephalopathy by benzodiazepine receptor ligands. Gammal SH; Basile AS; Geller D; Skolnick P; Jones EA Hepatology; 1990 Mar; 11(3):371-8. PubMed ID: 2155865 [TBL] [Abstract][Full Text] [Related]
8. Alterations of GABA-A and dopamine D-2 brain receptors in dogs with portal-systemic encephalopathy. Zeneroli ML; Baraldi M; Ventura E; Vezzelli C; Tofanetti O; Germini M; Casciarri I Life Sci; 1991; 48(1):37-50. PubMed ID: 1846016 [TBL] [Abstract][Full Text] [Related]
9. NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances. Jones EA; Skolnick P; Gammal SH; Basile AS; Mullen KD Ann Intern Med; 1989 Apr; 110(7):532-46. PubMed ID: 2538099 [TBL] [Abstract][Full Text] [Related]
10. Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. Albrecht J; Jones EA J Neurol Sci; 1999 Nov; 170(2):138-46. PubMed ID: 10617392 [TBL] [Abstract][Full Text] [Related]
11. Metabolism and brain uptake of gamma-aminobutyric acid in galactosamine-induced hepatic encephalopathy in rats. Zeneroli ML; Iuliano E; Racagni G; Baraldi M J Neurochem; 1982 May; 38(5):1219-22. PubMed ID: 7062047 [TBL] [Abstract][Full Text] [Related]
12. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Zimmermann C; Ferenci P; Pifl C; Yurdaydin C; Ebner J; Lassmann H; Roth E; Hörtnagl H Hepatology; 1989 Apr; 9(4):594-601. PubMed ID: 2564368 [TBL] [Abstract][Full Text] [Related]
13. Autoradiographic analysis of GABA-benzodiazepine receptors in an animal model of acute hepatic encephalopathy. Rössle M; Deckert J; Jones EA Hepatology; 1989 Aug; 10(2):143-7. PubMed ID: 2545587 [TBL] [Abstract][Full Text] [Related]
14. Experimental hepatic encephalopathy: changes in the binding of gamma-aminobutyric acid. Baraldi M; Zeneroli ZL Science; 1982 Apr; 216(4544):427-9. PubMed ID: 6280279 [TBL] [Abstract][Full Text] [Related]
15. Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABAA-benzodiazepine receptor complex in a rabbit model of fulminant hepatic failure. Bassett ML; Mullen KD; Skolnick P; Jones EA Gastroenterology; 1987 Nov; 93(5):1069-77. PubMed ID: 2820828 [TBL] [Abstract][Full Text] [Related]
16. Down regulation of striatal dopamine receptors in experimental hepatic encephalopathy. Baraldi M; Zeneroli ML; Ricci P; Caselgrandi E; Ventura E Life Sci; 1983 Mar; 32(13):1417-25. PubMed ID: 6403789 [TBL] [Abstract][Full Text] [Related]
17. Toxins in hepatic encephalopathy: the role of the synergistic effect of ammonia, mercaptans and short chain fatty acids. Baraldi M; Pinelli G; Ricci P; Zeneroli ML Arch Toxicol Suppl; 1984; 7():103-5. PubMed ID: 6097201 [TBL] [Abstract][Full Text] [Related]
18. Hepatic encephalopathy in cirrhotic and portacaval shunted dogs: lack of changes in brain GABA uptake, brain GABA levels, brain glutamic acid decarboxylase activity and brain postsynaptic GABA receptors. Roy S; Pomier-Layrargues G; Butterworth RF; Huet PM Hepatology; 1988; 8(4):845-9. PubMed ID: 2839406 [TBL] [Abstract][Full Text] [Related]
19. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status. Jones EA; Schafer DF; Ferenci P; Pappas SC Yale J Biol Med; 1984; 57(3):301-16. PubMed ID: 6093394 [TBL] [Abstract][Full Text] [Related]
20. Benzodiazepine receptor ligands are elevated in an animal model of hepatic encephalopathy: relationship between brain concentration and severity of encephalopathy. Yurdaydin C; Gu ZQ; Nowak G; Fromm C; Holt AG; Basile AS J Pharmacol Exp Ther; 1993 May; 265(2):565-71. PubMed ID: 8388453 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]